Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Classic

Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually.

Thorpe KE, Joski P, Johnston KJ. Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually. Health Aff (Millwood). 2018;37(4):662-669. doi:10.1377/hlthaff.2017.1153.

Save
Print
April 4, 2018
Thorpe KE, Joski P, Johnston KJ. Health Aff (Millwood). 2018;37(4):662-669.
View more articles from the same authors.

Infections with antibiotic-resistant organisms are increasingly common in hospitals and ambulatory care, primarily driven by overuse of antibiotics for treatment of nonbacterial illnesses. This economic analysis found that antibiotic-resistant infections have doubled in incidence since 2002, and they add approximately $1,400 to the cost of care for each patient with an antibiotic-resistant infection. The study was performed using data from the Medical Expenditure Panel Survey, which is conducted by AHRQ. This survey does not include data on institutionalized adults, such as residents of long-term care facilities. Since antibiotic-resistant infections are common in these patients, this study may actually underestimate the total economic burden of these infections. The devastating effects of an antibiotic-resistant infection for a health care practitioner were vividly illustrated in a PSNet perspective.

Save
Print
Cite
Citation

Thorpe KE, Joski P, Johnston KJ. Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually. Health Aff (Millwood). 2018;37(4):662-669. doi:10.1377/hlthaff.2017.1153.

Related Resources From the Same Author(s)
Related Resources